organization · Reporting owner
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VYCOR MEDICAL INCVYCO · Entity 8497 | 10% owner | September 30, 2022 | October 18, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VYCOR MEDICAL INC
Report date September 30, 2022 · Filed October 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 20,340,520 |
Reported balance
After 2022-09-30 transaction · row 1
1 source rowRow 1 · 2022-09-30 · Other · Acquired 535,714 · Balance 20,340,520 F1: Shares issued on account of accrued consultancy fees as of September 30, 2022 |
| Series D Preferred StockSEC Table I · non-derivative | Direct | 188,363 |
Reported balance
Holding disclosure · report date 2022-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 188,363 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares issued on account of accrued consultancy fees as of September 30, 2022
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 18, 2022 20:47 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.11 | $56,785.68 |
DisclosureSEC source: 0001493152-22-028659 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,340,520 F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2022 Read SEC document |
| June 30, 2022 Filed Jul 13, 2022 10:07 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.14 | $73,928.53 |
DisclosureSEC source: 0001493152-22-019121 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,804,806 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2022 Read SEC document |
| March 31, 2022 Filed Apr 13, 2022 21:20 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.09 | $45,535.69 |
DisclosureSEC source: 0001493152-22-009848 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,269,092 F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2022 Read SEC document |
| September 30, 2021 Filed Oct 8, 2021 17:19 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.14 | $77,142.82 |
DisclosureSEC source: 0001493152-21-025019 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,197,664 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2021 Read SEC document |
| September 30, 2021 Filed Jan 18, 2022 11:15 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.10 | $51,964.26 |
DisclosureSEC source: 0001493152-22-001390 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,733,378 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2021 Read SEC document |
| June 30, 2021 Filed Jul 20, 2021 16:12 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.14 | $74,999.96 |
DisclosureSEC source: 0001493152-21-017286 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,661,950 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2021 Read SEC document |
| March 31, 2021 Filed Apr 8, 2021 10:33 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-21-008264 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,126,236 F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2021. Read SEC document |
| December 31, 2020 Filed Jan 11, 2021 20:19 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-21-000733 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,590,522 F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2020. Read SEC document |
| September 30, 2020 Filed Oct 6, 2020 21:18 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-20-019041 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,054,808 F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2020. Read SEC document |
| June 30, 2020 Filed Jul 8, 2020 01:35 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-20-012773 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,519,094 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2020. Read SEC document |
| March 31, 2020 Filed Apr 7, 2020 10:15 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-20-005942 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,983,381 F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2020. Read SEC document |
| December 31, 2019 Filed Jan 7, 2020 11:04 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-20-000283 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,447,667 F1 · kind: Shares issued on account of accrued consultancy fees as of December 31, 2019. Read SEC document |
| September 30, 2019 Filed Oct 9, 2019 18:53 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-19-015299 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,911,952 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2019. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:35 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-19-010154 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,376,238 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2019. Read SEC document |
| March 31, 2019 Filed Apr 3, 2019 19:28 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-19-004816 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,840,524 F1 · kind: Shares issued on account of accrued consultancy fees as of March 31, 2019. Read SEC document |
| December 31, 2018 Filed Jan 8, 2019 18:42 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 535,714 | $0.21 | $112,499.94 |
DisclosureSEC source: 0001493152-19-000301 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,304,810 F1 · kind: Shares issued on account of accrued consultancy fees as of December, 2018. Read SEC document |
| September 30, 2018 Filed Oct 23, 2018 13:28 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 387,931 | $0.29 | $112,499.99 |
DisclosureSEC source: 0001493152-18-014774 · ownership.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,769,096 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2018. Read SEC document |
| June 30, 2018 Filed Jul 11, 2018 21:29 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 340,909 | $0.33 | $112,499.97 |
DisclosureSEC source: 0001493152-18-009905 · form4.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,381,165 F1 · kind: Shares issued on account of accrued consultancy fees as of June 30, 2018. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 1,924,697 | $0.43 Strike: $0.30 | $827,619.71 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · derivative · entry 10 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,924,697 shares Expires 2020-01-10 F4 · kind: Cashless exercise of 1,924,697 Warrants to purchase common stock at $0.27 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 351,204 | $0.43 Strike: $0.27 | $151,017.72 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · derivative · entry 9 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 351,204 shares Expires 2020-02-22 F3 · kind: Cashless exercise of 351,204 Warrants to purchase common stock at $0.27 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 438,053 | $0.43 Strike: $0.27 | $188,362.79 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · derivative · entry 8 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 438,053 shares Expires 2022-08-04 F2 · kind: Cashless exercise of 438,053 Warrants to purchase common stock at $0.30 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 716,167 | $0.43 | $307,951.81 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 6 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,040,256 F4 · kind: Cashless exercise of 1,924,697 Warrants to purchase common stock at $0.27 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 130,681 | $0.43 | $56,192.83 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 5 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,324,089 F3 · kind: Cashless exercise of 351,204 Warrants to purchase common stock at $0.27 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 132,435 | $0.43 | $56,947.05 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 4 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,193,408 F2 · kind: Cashless exercise of 438,053 Warrants to purchase common stock at $0.30 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 234,375 | $0.48 | $112,500.00 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 3 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,060,973 F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2017, December 31, 2017 and March 31, 2018, respectively. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 54,055 | $0.37 | $20,000.35 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,826,598 F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2017, December 31, 2017 and March 31, 2018, respectively. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 18:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 401,786 | $0.28 | $112,500.08 |
DisclosureSEC source: 0001493152-18-005700 · form4.xml · nonDerivative · entry 1 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,772,543 F1 · kind: Shares issued on account of accrued consultancy fees as of September 30, 2017, December 31, 2017 and March 31, 2018, respectively. Read SEC document |
| February 01, 2018 Filed Feb 10, 2018 00:59 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 250,000 | $0.37 | $92,500.00 |
DisclosureSEC source: 0001493152-18-001780 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,370,757 F1 · shares: Issued pursuant to Fountain head Consultancy Agreement Read SEC document |
| August 05, 2017 Filed Sep 15, 2017 19:05 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 438,053 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-17-010662 · form4.xml · derivative · entry 6 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,053 Underlying: Common Stock · 438,053 shares Expires 2022-08-04 F2 · kind: Warrants issued pursuant to Share Exchange Agreement dated August 5, 2014. Read SEC document |
| August 05, 2017 Filed Feb 10, 2018 00:59 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 438,053 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-18-001780 · form4.xml · derivative · entry 6 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,053 Underlying: Common Stock · 438,053 shares Expires 2022-08-04 Read SEC document |
| June 30, 2017 Filed Jul 21, 2017 19:41 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 501,429 | $0.21 | $105,300.09 |
DisclosureSEC source: 0001493152-17-008081 · form4.xml · nonDerivative · entry 3 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,120,757 F1 · shares: Issuance Pursuant to Fountainhead Consultancy Agreement. Read SEC document |
| April 30, 2017 Filed Jul 21, 2017 19:41 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 1,571,429 | $0.21 | $330,000.09 |
DisclosureSEC source: 0001493152-17-008081 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,619,328 F1 · shares: Issuance Pursuant to Fountainhead Consultancy Agreement. Read SEC document |
| March 31, 2017 Filed Apr 6, 2017 20:03 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 142,857 | $0.21 | $29,999.97 |
DisclosureSEC source: 0001493152-17-003591 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,047,899 F1 · shares: Payment of consulting fee in stock. Read SEC document |
| March 31, 2017 Filed Apr 11, 2017 10:15 UTC Amendment | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantOption · Derivative | 660,000 | $0.27 Strike: $0.27 | $178,200.00 |
DisclosureSEC source: 0001493152-17-003717 · form4a.xml · derivative · entry 10 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 660,000 Underlying: Common Stock · 660,000 shares Expires not disclosed F1 · date: Grant of option on March 31, 2017. Option vesting is subject to achievement of certain milestones prior to March 31, 2018. F2 · derivative.exercise_date: Exercisable upon achievement of certain milestones prior to March 31, 2018 for a period of three years from date of vesting. F2 · derivative.expiration_date: Exercisable upon achievement of certain milestones prior to March 31, 2018 for a period of three years from date of vesting. Read SEC document |
| March 31, 2017 Filed Apr 11, 2017 10:15 UTC Amendment | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 142,857 | $0.21 | $29,999.97 |
DisclosureSEC source: 0001493152-17-003717 · form4a.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,047,899 Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 22:20 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 351,204 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001493152-17-002076 · form4.xml · derivative · entry 9 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,204 Underlying: Common Stock · 351,204 shares Expires 2010-02-22 F1 · kind: Acquired in connection with purchase of 351,204 shares of common stock in a private placement by the issuer. Read SEC document |
| February 23, 2017 Filed Mar 2, 2017 22:20 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 351,204 | $0.21 | $73,752.84 |
DisclosureSEC source: 0001493152-17-002076 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,905,042 Read SEC document |
| January 11, 2017 Filed Jan 19, 2017 22:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 1,924,697 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001493152-17-000652 · form4.xml · derivative · entry 8 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,924,697 Underlying: Common Stock · 1,924,697 shares Expires 2020-01-10 F1 · kind: Acquired in connection with purchase of 1,924,697 shares of common stock in a private placement by the issuer. Read SEC document |
| January 11, 2017 Filed Jan 19, 2017 22:40 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 1,924,697 | $0.21 | $404,186.37 |
DisclosureSEC source: 0001493152-17-000652 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,553,838 Read SEC document |
| December 31, 2016 Filed Jan 13, 2017 19:01 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 90,909 | $0.33 | $29,999.97 |
DisclosureSEC source: 0001493152-17-000448 · form4.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,629,141 Read SEC document |
| September 30, 2016 Filed Oct 11, 2016 20:51 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | GrantCommon Stock par value $0.0001 | 88,235 | $0.34 | $29,999.90 |
DisclosureSEC source: 0001354488-16-008378 · issuerdirect_section16.xml · nonDerivative · entry 2 FOUNTAINHEAD CAPITAL MANAGEMENT LTD · CIK 0001399726 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,538,232 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.